Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients.

Episode Summary

Introduction

Dr. Auric Bishop, a cardiologist, author, and CEO of the Healthy Heart Network, hosts this episode to discuss omega-3 fish oils and marine triglycerides—what they are, how they work, and what current research reveals about their effectiveness. With heart disease causing significant mortality in Australia, the episode aims to help listeners understand the science behind these popular supplements and their role in cardiovascular health.

Key Takeaways

• Not all omega-3 fish oil supplements are equal; over-the-counter varieties are classified as food products and only need to meet food-quality standards, not pharmaceutical standards, resulting in variable quality and purity.

• A 2014 New Zealand study found that only 3 out of 32 common fish oil supplements contained the EPA and DHA amounts claimed on their labels, with most containing only 60-70% of advertised levels and excessive oxidation that reduces effectiveness.

• Over-the-counter fish oil supplements often contain saturated fats and other impurities as filler, which may actually raise LDL cholesterol and counteract the intended cardiovascular benefits.

• Research shows that EPA (eicosapentaenoic acid) alone has demonstrated clinical benefits in reducing major adverse coronary events, while the combination of EPA and DHA together has not replicated these results.

• EPA works through multiple mechanisms including maintaining cholesterol distribution, preserving membrane stability, reducing triglyceride levels, decreasing inflammation, and stabilizing vulnerable arterial plaques to prevent future cardiac events.

• Large clinical trials using low-dose omega-3 supplements (Vital, Ascend, Strength) showed inconsistent or no cardiovascular benefits, but three high-dose EPA trials (JELUS, RESPECT, REDUCER) demonstrated 15-20% relative risk reduction in secondary prevention.

• The REDUCER trial showed that high-dose EPA (4 grams daily) provided significant cardiovascular benefits in patients with established heart disease or elevated triglycerides despite already being on cholesterol-lowering statin therapy.

• The most practical and effective way to obtain beneficial omega-3 levels is eating fresh, fatty fish once or twice weekly (200 grams provides approximately 20 grams each of EPA and DHA), which is more reliable than over-the-counter supplements.

• Pharmaceutical-grade prescription EPA products are highly purified and regulated but are only beginning to become available in Australia, making fresh fish consumption the current best alternative for most people.